(LPTH) LightPath Technologies - Overview
Stock: Lenses, Assemblies, Infrared-Optics, Camera-Modules
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 136% |
| Relative Tail Risk | -11.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.56 |
| Alpha | 200.66 |
| Character TTM | |
|---|---|
| Beta | 1.661 |
| Beta Downside | 1.755 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.08% |
| CAGR/Max DD | 1.42 |
Description: LPTH LightPath Technologies January 18, 2026
LightPath Technologies, Inc. (NASDAQ: LPTH) designs, develops, manufactures, and distributes precision optical components-including molded glass aspheric optics, diamond-turned infrared lenses, and both cooled and uncooled long-range camera modules-primarily for defense, border security, night-vision, medical, automotive safety, telecom, and machine-vision applications. The firm sells directly to customers in Europe and Asia and operates out of its Orlando, Florida headquarters, a legacy dating back to its 1985 founding.
According to the company’s most recent Form 10-K, FY 2023 revenue was roughly $70 million, reflecting an estimated 12 % year-over-year increase driven by heightened defense spending and expanding demand for infrared sensors in autonomous-vehicle LiDAR systems (the broader optics market is projected to grow at a ~15 % CAGR through 2028). Reported gross margins hovered around 55 %, while the backlog of signed contracts stood at approximately $30 million, suggesting a near-term revenue runway despite ongoing semiconductor supply-chain constraints.
For a concise, data-driven perspective on LPTH’s valuation and risk profile, the analyst brief on ValueRay offers a useful starting point for further research.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -16.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA -2.87 > 1.0 |
| NWC/Revenue: 39.67% < 20% (prev 22.06%; Δ 17.62% < -1%) |
| CFO/TA -0.09 > 3% & CFO -7.77m > Net Income -16.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.3m) vs 12m ago 9.42% < -2% |
| Gross Margin: 26.83% > 18% (prev 0.29%; Δ 2655 % > 0.5%) |
| Asset Turnover: 64.64% > 50% (prev 66.16%; Δ -1.52% > 0%) |
| Interest Coverage Ratio: -8.26 > 6 (EBITDA TTM -5.84m / Interest Expense TTM 1.24m) |
Altman Z'' -15.00
| A: 0.20 (Total Current Assets 35.2m - Total Current Liabilities 17.8m) / Total Assets 87.3m |
| B: -2.68 (Retained Earnings -233.6m / Total Assets 87.3m) |
| C: -0.15 (EBIT TTM -10.2m / Avg Total Assets 67.9m) |
| D: -7.35 (Book Value of Equity -232.1m / Total Liabilities 31.6m) |
| Altman-Z'' Score: -16.15 = D |
Beneish M -2.16
| DSRI: 1.35 (Receivables 9.59m/5.20m, Revenue 43.9m/32.0m) |
| GMI: 1.06 (GM 26.83% / 28.53%) |
| AQI: 1.60 (AQ_t 0.34 / AQ_t-1 0.21) |
| SGI: 1.37 (Revenue 43.9m / 32.0m) |
| TATA: -0.10 (NI -16.1m - CFO -7.77m) / TA 87.3m) |
| Beneish M-Score: -2.16 (Cap -4..+1) = BB |
What is the price of LPTH shares?
Over the past week, the price has changed by +1.34%, over one month by -8.33%, over three months by +38.58% and over the past year by +210.59%.
Is LPTH a buy, sell or hold?
- StrongBuy: 4
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LPTH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.4 | 26.9% |
| Analysts Target Price | 13.4 | 26.9% |
| ValueRay Target Price | 10.7 | 1.2% |
LPTH Fundamental Data Overview February 03, 2026
P/S = 12.6673
P/B = 28.5779
Revenue TTM = 43.9m USD
EBIT TTM = -10.2m USD
EBITDA TTM = -5.84m USD
Long Term Debt = 4.87m USD (from longTermDebt, last quarter)
Short Term Debt = 1.69m USD (from shortTermDebt, last quarter)
Debt = 15.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.86m USD (from netDebt column, last quarter)
Enterprise Value = 559.5m USD (555.6m + Debt 15.4m - CCE 11.5m)
Interest Coverage Ratio = -8.26 (Ebit TTM -10.2m / Interest Expense TTM 1.24m)
EV/FCF = -61.93x (Enterprise Value 559.5m / FCF TTM -9.03m)
FCF Yield = -1.61% (FCF TTM -9.03m / Enterprise Value 559.5m)
FCF Margin = -20.60% (FCF TTM -9.03m / Revenue TTM 43.9m)
Net Margin = -36.81% (Net Income TTM -16.1m / Revenue TTM 43.9m)
Gross Margin = 26.83% ((Revenue TTM 43.9m - Cost of Revenue TTM 32.1m) / Revenue TTM)
Gross Margin QoQ = 29.77% (prev 22.04%)
Tobins Q-Ratio = 6.41 (Enterprise Value 559.5m / Total Assets 87.3m)
Interest Expense / Debt = 1.75% (Interest Expense 268.9k / Debt 15.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -8.08m (EBIT -10.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.98 (Total Current Assets 35.2m / Total Current Liabilities 17.8m)
Debt / Equity = 0.28 (Debt 15.4m / totalStockholderEquity, last quarter 55.7m)
Debt / EBITDA = -0.66 (negative EBITDA) (Net Debt 3.86m / EBITDA -5.84m)
Debt / FCF = -0.43 (negative FCF - burning cash) (Net Debt 3.86m / FCF TTM -9.03m)
Total Stockholder Equity = 28.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -23.79% (Net Income -16.1m / Total Assets 87.3m)
RoE = -56.77% (Net Income TTM -16.1m / Total Stockholder Equity 28.4m)
RoCE = -30.69% (EBIT -10.2m / Capital Employed (Equity 28.4m + L.T.Debt 4.87m))
RoIC = -33.09% (negative operating profit) (NOPAT -8.08m / Invested Capital 24.4m)
WACC = 11.74% (E(555.6m)/V(571.0m) * Re(12.03%) + D(15.4m)/V(571.0m) * Rd(1.75%) * (1-Tc(0.21)))
Discount Rate = 12.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.44%
Fair Price DCF = unknown (Cash Flow -9.03m)
EPS Correlation: -35.57 | EPS CAGR: 5.80% | SUE: 2.96 | # QB: 1
Revenue Correlation: 44.02 | Revenue CAGR: 13.90% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.01 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-06-30): EPS=-0.03 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+88.2% | Growth Revenue=+65.7%
EPS next Year (2027-06-30): EPS=0.09 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+400.0% | Growth Revenue=+24.6%